Primecap Management
HCAT icon

Primecap Management’s Health Catalyst HCAT Stock Holding History

Primecap Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-340,418
Closed -$432K – 328
2026
Q1 		$432K Hold
340,418
– – ﹤0.01% 313
2025
Q4 		$814K Sell
340,418
-1,028,649
-75% -$2.81M ﹤0.01% 311
2025
Q3 		$3.9M Sell
1,369,067
-617,620
-31% -$2.11M ﹤0.01% 286
2025
Q2 		$7.49M Sell
1,986,687
-18,429
-0.9% -$72.5K 0.01% 273
2025
Q1 		$9.08M Buy
2,005,116
+72,499
+4% +$384K 0.01% 259
2024
Q4 		$13.7M Sell
1,932,617
-471,845
-20% -$3.76M 0.01% 245
2024
Q3 		$19.6M Buy
2,404,462
+25,000
+1% +$181K 0.01% 233
2024
Q2 		$15.2M Buy
2,379,462
+305,079
+15% +$1.96M 0.01% 239
2024
Q1 		$15.6M Buy
2,074,383
+654,806
+46% +$5.98M 0.01% 241
2023
Q4 		$13.1M Buy
1,419,577
+299,139
+27% +$2.44M 0.01% 250
2023
Q3 		$11.3M Buy
1,120,438
+519,004
+86% +$6.2M 0.01% 251
2023
Q2 		$7.52M Buy
601,434
+11,100
+2% +$132K 0.01% 268
2023
Q1 		$6.89M Buy
590,334
+119,000
+25% +$1.52M 0.01% 270
2022
Q4 		$5.01M Sell
471,334
-910
-0.2% -$8.79K ﹤0.01% 275
2022
Q3 		$4.58M Buy
472,244
+166,000
+54% +$2.2M ﹤0.01% 277
2022
Q2 		$4.44M Buy
306,244
+34,717
+13% +$592K ﹤0.01% 288
2022
Q1 		$7.09M Buy
271,527
+31,283
+13% +$888K 0.01% 276
2021
Q4 		$9.52M Buy
240,244
+7,335
+3% +$334K 0.01% 266
2021
Q3 		$11.6M Sell
232,909
-106
-0% -$5.78K 0.01% 261
2021
Q2 		$12.9M Buy
233,015
+11,000
+5% +$586K 0.01% 254
2021
Q1 		$10.4M Buy
222,015
+121,106
+120% +$5.87M 0.01% 263
2020
Q4 		$4.39M Buy
100,909
+36,000
+55% +$1.33M ﹤0.01% 279
2020
Q3 		$2.38M Buy
64,909
+20,000
+45% +$679K ﹤0.01% 279
2020
Q2 		$1.31M Buy
+44,909
New +$1.24M ﹤0.01% 287

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management's HCAT Position: Q2 2026 in Review

Primecap Management sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 340,418 shares — an estimated $432K sold.

Primecap Management first reported a position in HCAT in Q2 2020 and held it in 24 quarters. The position peaked at $19.6M in Q3 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Primecap Management reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Primecap Management sold 340,418 Health Catalyst shares in Q2 2026, an estimated $432K.
  • Primecap Management first reported a position in Health Catalyst in Q2 2020 and held it in 24 quarters.
  • Primecap Management's Health Catalyst position peaked at $19.6M in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.